3-hydroxy-4-methoxyphenethylamine has been researched along with Parkinson Disease in 1 studies
3-hydroxy-4-methoxyphenethylamine: cardioactive constituent of a soft coral; cpd is 4-O-methyldopamine; RN given refers to parent cpd
4-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 4 is replaced by a methoxy group.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishimitsu, T | 1 |
| Hirose, S | 1 |
| Asahara, K | 1 |
| Imaizumi, M | 1 |
1 other study available for 3-hydroxy-4-methoxyphenethylamine and Parkinson Disease
| Article | Year |
|---|---|
The formation of 3-hydroxy-4-methoxyphenylalanine and 3-hydroxy-4-methoxyphenethylamine in plasma during L-DOPA therapy in patients with Parkinson's disease.
Topics: Aged; Dopamine; Humans; Levodopa; Methyltyrosines; Parkinson Disease; Tyrosine | 1984 |